PHARMACEUTICAL COMPOSITION CONTAINING CARBOCYCLIC NUCLEOSIDE DERIVATIVE FOR PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE 19

The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus disease 19 (COVID-19) and, specifically, to a pharmaceutical composition containing a carbocyclic nucleoside derivative represented by chemical formula A-1 or chemical formula A-2 or a pharmaceut...

Full description

Saved in:
Bibliographic Details
Main Authors LEE, Hyuk Woo, JANG, Hyu Jeong, KANG, Ji Yoon, SON, Seo Hyun, SEO, Seong Wook
Format Patent
LanguageEnglish
Published 31.08.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus disease 19 (COVID-19) and, specifically, to a pharmaceutical composition containing a carbocyclic nucleoside derivative represented by chemical formula A-1 or chemical formula A-2 or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: AU20220227430